News Conference News VIVA 2024 It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now? L.A. McKeown November 14, 2024
News Conference News VIVA 2023 New Carotid Stent Systems Associated With Low Stroke Risk L.A. McKeown November 09, 2023
News Conference News LINC 2023 Good Real-World Outcomes Seen With Next-Generation Carotid Stent L.A. McKeown June 06, 2023
News Conference News ESOC 2023 Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting Todd Neale June 02, 2023
News Conference News ESOC 2023 ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy Todd Neale May 26, 2023
News Conference News ESC 2021 ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients Todd Neale August 29, 2021
News Conference News PCR London Valves 2019 Two Small Series Support Role for Cerebral Protection in TAVR Michael O'Riordan November 18, 2019
News Conference News ISC 2019 Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade Todd Neale February 11, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News ISET 2018 Next-Generation Large-Bore Closure Devices Arrive Caitlin E. Cox February 05, 2018
News Conference News ISC 2016 ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms Todd Neale February 17, 2016
News Conference News ISET 2016 To Check or Not to Check? Carotid Screening Should be Limited to Highly Selected Patients, Say Experts Michael O'Riordan February 07, 2016
News Conference News TCT 2015 CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA Todd Neale October 14, 2015